The key findings of our present study are that PCAT6 is significantly elevated in ovarian cancer tissues and that this elevation is associated with advanced TNM stage and poor prognosis, indicating that PCAT6 is a potential diagnostic and prognostic marker for ovarian cancer. This evidence concerns the gene PCAT6 and ovarian cancer.